Posted in | News | Lighting

PureSpectrum Progresses in Finalizing Product Launch of CFL and Linear Fluorescent Products

PureSpectrum, Inc. (OTCBB: PSRU) has continued to make progress toward finalizing a product launch plan that will include additional products in both the Compact Fluorescent Lamp (CFL) and linear fluorescent categories.

Sales momentum has continued to build for the company’s 20-watt dimmable CFL introduced earlier this year, and inventory to fulfill purchase orders is warehoused in the United States. A product shipment cleared US customs this week, and an additional container shipment is expected to arrive during the first week of December. PureSpectrum Vice President of Sales Garth Kullman said the company has received and fulfilled initial purchase orders for the 20-watt dimmable CFL. He also said additional purchase orders are in progress, and the company’s manufacturer’s representatives and distribution partners are receiving multiple requests for quotes from utilities and commercial entities which could become future purchase orders.

Kullman also said based on recent feedback from manufacturing and engineering partners, PureSpectrum expects to be able to launch multiple additional CFL products as well as several linear fluorescent products in 2010. Pending the results of a final engineering and manufacturing evaluation taking place this week in China, the company anticipates that Energy Star testing can begin later this month for at least two additional dimmable CFL products.

As the company continues its efforts to immediately expand its CFL product line, PureSpectrum’s sales team concluded a direct mail campaign intended to stimulate not only purchase orders but also brand familiarity within several potentially applicable market sectors for dimmable lighting products. The campaign included delivering approximately 1,700 samples of the 20-watt dimmable CFL to a target list of more than 1,200 distributors, retailers, utilities, retail outlets, hotels and medical facilities in the United States.

Members of PureSpectrum’s engineering team are also meeting this week with a Chinese manufacturer regarding dimmable linear fluorescent fixtures which the company believes could be added to its product catalog in the near future. As the relationship with the manufacturer has solidified during the past month, PureSpectrum’s sales staff has worked to put in place multiple potential sales channels in anticipation of the dimmable linear fluorescent fixtures’ availability.

“We are acutely aware that our shareholders have experienced significant concern during the past week following the company’s move to the OTC Bulletin Board and the drop in our price per share once trading began, but I want to assure our shareholders that we are continuing the execution of our business plan in order to put the company in position to make progress toward meeting our corporate goals,” said PureSpectrum Chairman and CEO Lee Vanatta. “Prior to encountering unforeseen and unfortunate engineering and manufacturing delays, we told our shareholders we would be introducing multiple CFL products. We expect to be able to launch at least two additional SKUs in the first quarter of 2010 and introduce the company’s first dimmable linear fluorescent product to give us an appropriate platform to meet our stated revenue goal of $66 million in 2010. Although the company did expect its stock to experience some selling as restricted shares became free trading, we are sensitive to the anxiety caused by the downward trend in the stock price. But in light of the progress the company has made as well as the positive developments in the areas of sales and product development, we ask that our shareholders be patient during this time of transition as we take measures that we believe give the company the best chance for short term and long term viability.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.